Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Br J Surg. 2019 Nov;106(12):1590-1601. doi: 10.1002/bjs.11295. Epub 2019 Aug 27.
Initial recurrence mapping of resected pancreatic ductal adenocarcinoma (PDAC) could help in stratifying patient subpopulations for optimal postoperative follow-up. The aim of this systematic review and meta-analysis was to investigate the initial recurrence patterns of PDAC and to correlate them with clinicopathological factors.
MEDLINE and Web of Science databases were searched systematically for studies reporting first recurrence patterns after PDAC resection. Data were extracted from the studies selected for inclusion. Pooled odds ratios (ORs) and 95 per cent confidence intervals were calculated to determine the clinicopathological factors related to the recurrence sites. The weighted average of median overall survival was calculated.
Eighty-nine studies with 17 313 patients undergoing PDAC resection were included. The weighted median rates of initial recurrence were 20·8 per cent for locoregional sites, 26·5 per cent for liver, 11·4 per cent for lung and 13·5 per cent for peritoneal dissemination. The weighted median overall survival times were 19·8 months for locoregional recurrence, 15·0 months for liver recurrence, 30·4 months for lung recurrence and 14·1 months for peritoneal dissemination. Meta-analysis revealed that R1 (direct) resection (OR 2·21, 95 per cent c.i. 1·12 to 4·35), perineural invasion (OR 5·19, 2·79 to 9·64) and positive peritoneal lavage cytology (OR 5·29, 3·03 to 9·25) were significantly associated with peritoneal dissemination as initial recurrence site. Low grade of tumour differentiation was significantly associated with liver recurrence (OR 4·15, 1·71 to 10·07).
Risk factors for recurrence patterns after surgery could be considered for specific surveillance and treatments for patients with pancreatic cancer.
切除后的胰腺导管腺癌(PDAC)的初始复发图谱有助于对患者亚群进行分层,以进行最佳的术后随访。本系统评价和荟萃分析的目的是研究 PDAC 的初始复发模式,并将其与临床病理因素相关联。
系统地检索了 MEDLINE 和 Web of Science 数据库,以查找报告 PDAC 切除后首次复发模式的研究。从入选的研究中提取数据。计算了合并的优势比(OR)和 95%置信区间,以确定与复发部位相关的临床病理因素。计算了加权平均中位总生存期。
纳入了 89 项研究,共 17313 例 PDAC 切除术患者。局部复发的加权中位数率为 20.8%,肝转移为 26.5%,肺转移为 11.4%,腹膜播散为 13.5%。局部复发的加权中位数总生存时间为 19.8 个月,肝转移为 15.0 个月,肺转移为 30.4 个月,腹膜播散为 14.1 个月。荟萃分析显示,R1(直接)切除(OR 2.21,95%置信区间 1.12 至 4.35)、神经周围侵犯(OR 5.19,2.79 至 9.64)和阳性腹膜灌洗细胞学(OR 5.29,3.03 至 9.25)与腹膜播散作为初始复发部位显著相关。肿瘤分化程度低与肝转移显著相关(OR 4.15,1.71 至 10.07)。
术后复发模式的风险因素可用于考虑对胰腺癌患者进行特定的监测和治疗。